Hypoallergenic fragment of Par j 2 increases functional expression of Toll-like receptors in atopic children

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 12, 2006, Pages 1459-1466

  Pace, E ^a   Duro, G ^a   Grutta, S La ^a   Ferraro, M ^a   Bruno, A ^a   Bousquet, J ^b   Bonsignore, G ^a   Gjomarkaj, M ^a  

^a CNR   (Italy)

^b INSERM   (France)

Author keywords

Allergy; Innate immunity; Th1 and Th2 responses

Indexed keywords

ALLERGEN; CD45RO ANTIGEN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; PROTEIN PAR J 2; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ATOPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PARIETARIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRICK TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SKIN TEST;

ADOLESCENT; ALLERGENS; CHILD; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; PEPTIDE FRAGMENTS; PLANT PROTEINS; TOLL-LIKE RECEPTORS;

EID: 33750506943     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01234.x     Document Type: Article

References (31)

1. Masullo M, Mariotta S, Torrelli L, Graziani E, Anticoli S, Mannino F. Respiratory allergy to Parietaria pollen in 348 subjects. Allergol Immunopathol 1996;24:3-6.
2. Stumvoll S, Westritschnig K, Lidholm J, Spitzauer S, Colombo P, Duro G et al. Identification of cross-reactive and genuine Parietaria judaica pollen allergens. J Allergy Clin Immunol 2003;111:974-979.
3. Duro G, Colombo P, Costa MA, Izzo V, Porcasi R, Di Fiore R et al. cDNA cloning, sequence analysis and allergological characterization of Par j 2.0101, a new major allergen of the Parietaria judaica pollen. FEBS Lett 1996;399:295-298.
4. Duro G, Colombo P, Assunta Costa M, Izzo V, Porcasi R, Di Fiore R et al. Isolation and characterization of two cDNA clones coding for isoforms of the Parietaria judaica major allergen Par j 1.0101. Int Arch Allergy Immunol 1997;112:348-355.
5. Bonura A, Amoroso S, Locorotondo G, Di Felice G, Tinghino R, Geraci D et al. Hypoallergenic variants of the Parietaria judaica major allergen Par j 1: a member of the non-specific lipid transfer protein plant family. Int Arch Allergy Immunol 2001;126:32-40.
6. Magi M, Garcia L, Vandenbranden M, Palmantier R, Jacquet A. Heat denaturation affects the ProDer p 1 IgE reactivity and downregulates the development of the specific allergic response. J Allergy Clin Immunol 2004;114:545-552.
7. Racila DM, Kline JN. Perspectives in asthma: molecular use of microbial products in asthma prevention and treatment. J Allergy Clin Immunol 2005;116:1202-1205.
8. Cookson WO, Moffatt MF. Asthma: an epidemic in the absence of infection? Science 1997;275:41-42.
9. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L et al.; Allergy and Endotoxin Study Team. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002;347:869-877.
10. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005;6:769-776.
11. Weigt H, Muhlradt PF, Larbig M, Krug N, Braun A. The Toll-like receptor-2/6 agonist macrophage-activating lipopeptide-2 cooperates with IFN-gamma to reverse the Th2 skew in an in vitro allergy model. J Immunol 2004;172:6080-6086.
12. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy 2000;30(Suppl. 1):2-5.
13. Costa MA, Duro G, Izzo V, Colombo P, Mirisola MG, Locorotondo G et al. The IgE-binding epitopes of Par j 2rPar j 2, a major allergen of Parietaria judaica pollen, are heterogeneously recognized among allergic subjects. Allergy 2000;55:246-250.
14. Pace E, Profita M, Melis M, Bonanno A, Paterno A, Mody CH et al. LTB4 is present in exudative pleural effusions and contributes actively to neutrophil recruitment in the inflamed pleural space. Clin Exp Immunol 2004;135:519-527.
15. Lara-Marquez ML, Deykin A, Krinzman S, Listman J, Israel E, He H et al. Analysis of T-cell activation after bronchial allergen challenge in patients with atopic asthma. J Allergy Clin Immunol 1998;101:699-708.
16. Bellinghausen I, Brand U, Knop J, Saloga J. Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. J Allergy Clin Immunol 2000;105:988-996.
17. Gafvelin G, Thunberg S, Kronqvist M, Gronlund H, Gronneberg R, Troye-Blomberg M et al. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1. Int Arch Allergy Immunol 2005;138:59-66.
18. Bousquet J, Lockey R, Malling HJ, Alvarez-Cuesta E, Canonica GW, Chapman MD et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;81:401-405.
19. Akdis CA, Blesken T, Wymann D, Akdis M, Blaser K. Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants. Eur J Immunol 1998;28:914-925.
20. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004;112:352-363 (Review).
21. Higgins SC, Lavelle EC, McCann C, Keogh B, McNeela E, Byrne P et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol 2003;171:3119-3127.
22. Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med 1998;187:177-183.
23. Vandenbulcke L, Bachert C, Van Cauwenberge P, Claeys S. The innate immune system and its role in allergic disorders. Int Arch Allergy Immunol 2005;139:159-165.
24. Tulic MK, Fiset PO, Manoukian JJ, Frenkiel S, Lavigne F, Eidelman DH et al. Role of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not adults. Lancet 2004;363:1689-1697.
25. Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000;355:1680-1683.
26. Liu AH. Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol 2002;109:379-392.
27. Thorne PS, Kulhankova K, Yin M, Cohn R, Arbes SJ, Zeldin DC. Endotoxin exposure is a risk factor for asthma. Am J Respir Crit Care Med 2005;172:1371-1375.
28. Rodriguez D, Keller AC, Faquim-Mauro EL, de Macedo MS, Cunha FQ, Lefort J et al. Bacterial lipopolysaccharide signaling through toll like receptor 4 suppresses asthma like responses via nitric oxide synthase 2 activity. J Immunol 2003;171:1001-1008.
29. Saito A, Okazaki H, Sugawara I, Yamamoto K, Takizawa H. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol 2003;132:168-176.
30. Duncan MR, Berman B. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985;162:516-527.
31. Eickelberg O, Pansky A, Koehler E, Bihl M, Tamm M, Hildebrand P et al. Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts. FASEB J 2001;15:797-806.